Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in IntangiblesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZNCF) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Astrazeneca (AZNCF) over the last 15 years, with Q4 2025 value amounting to $4.0 million.

  • Astrazeneca's Exchange Rate Effect rose 10655.74% to $4.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $46.0 million, marking a year-over-year increase of 14946.24%. This contributed to the annual value of $46.0 million for FY2025, which is 14946.24% up from last year.
  • As of Q4 2025, Astrazeneca's Exchange Rate Effect stood at $4.0 million, which was up 10655.74% from -$12.0 million recorded in Q3 2025.
  • Over the past 5 years, Astrazeneca's Exchange Rate Effect peaked at $29.0 million during Q2 2025, and registered a low of -$67.0 million during Q1 2021.
  • Its 5-year average for Exchange Rate Effect is -$11.9 million, with a median of -$10.0 million in 2022.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first plummeted by 31818.18% in 2024, then skyrocketed by 58333.33% in 2025.
  • Over the past 5 years, Astrazeneca's Exchange Rate Effect (Quarter) stood at $11.0 million in 2021, then crashed by 336.36% to -$26.0 million in 2022, then crashed by 38.46% to -$36.0 million in 2023, then crashed by 69.44% to -$61.0 million in 2024, then soared by 106.56% to $4.0 million in 2025.
  • Its last three reported values are $4.0 million in Q4 2025, -$12.0 million for Q3 2025, and $29.0 million during Q2 2025.